financetom
Business
financetom
/
Business
/
Why Is ZIM Integrated Shipping Stock Falling Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Is ZIM Integrated Shipping Stock Falling Today?
May 21, 2024 9:02 AM

ZIM Integrated Shipping Services Ltd ( ZIM ) shares are trading lower after it reported a first-quarter FY24 sales increase of 14% Y/Y to $1.56 billion, missing the consensus of $1.57 billion.

The Haifa, Israel-based company generated an EPS of $0.75, vs a loss of $0.50 last year and missing the consensus of $1.69.

Carried volume in the quarter was 846 thousand TEUs, up 10% Y/Y. The average freight rate per TEU was $1,452 (+4% Y/Y).

Adjusted EBITDA rose 14% Y/Y to $427 million, with margins of 27% same as the prior year quarter.  

ZIM’s total cash position decreased by $442 million from $2.69 billion as of December 2023-end to $2.25 billion as of March-end.

Operating cash flow for the quarter was $326 million, compared to $174 million a year ago. 

ZIM’s net leverage ratio was 2.8x as of March-end, compared to 2.2x as of December 31, 2023. Capital expenditures were $24 million during the quarter versus $36 million a year ago.

Dividend: The Board of Directors declared a cash dividend per share of $0.23, payable on June 11 to shareholders of record as of June 4.

Eli Glickman, ZIM President & CEO, said, “Looking ahead, we now expect freight rates to remain stronger for longer than initially anticipated due to a combination of continued pressure on supply and availability of equipment and a recent uptick in demand.” 

“While the rate environment during the latter part of 2024 remains unknown, we are confident in ZIM’s strategic positioning as an agile container shipping player with a competitive cost- and fuel-efficient, modern fleet.”

“By year’s end, we expect the delivery of the final 16 out of 46 newbuild containerships that we secured, which include 28 LNG-powered vessels.”

2024 Outlook: ZIM raised the adjusted EBITDA outlook to $1.15 billion-$1.55 billion (from $850 million-$1.450 billion) and adjusted EBIT to zero-$400 million (from a loss of $300 million-profit of $300 million).

Price Action: ZIM shares are down 3.75% at $18.46 at the last check Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ConnectM Acquires Geo Impex, Securing Regulatory-Approved Site for AI-Driven Data Center and Multimodal Logistics Park Development
ConnectM Acquires Geo Impex, Securing Regulatory-Approved Site for AI-Driven Data Center and Multimodal Logistics Park Development
Nov 5, 2025
MARLBOROUGH, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. ( CNTM ) (“ConnectM” or the “Company”), a high-growth technology company powering the modern energy economy, today announced the acquisition of Geo Impex & Logistics Private Limited (“Geo Impex”), an India-based developer of sustainable logistics infrastructure. The transaction grants ConnectM and its subsidiary Keen Labs (www.keenlabs.ai) ownership of...
Starbucks workers union vote to authorize strike amid stalled talks
Starbucks workers union vote to authorize strike amid stalled talks
Nov 5, 2025
Nov 5 (Reuters) - Unionized Starbucks ( SBUX ) baristas voted to authorize an open-ended strike ahead of Starbucks' ( SBUX ) high-traffic holiday season, announced Starbucks Workers United on Wednesday. The union said workers are prepared to strike if a contract is not finalized by November 13, which is the company's Red Cup Day, and strike actions could hit...
Market Chatter: Trump to Announce Deal With Eli Lilly, Novo Nordisk on Weight Loss Drugs Thursday
Market Chatter: Trump to Announce Deal With Eli Lilly, Novo Nordisk on Weight Loss Drugs Thursday
Nov 5, 2025
01:26 PM EST, 11/05/2025 (MT Newswires) -- President Donald Trump is scheduled to announce at 11 a.m. Thursday a deal with Eli Lilly ( LLY ) and Novo Nordisk ( NVO ) on the price of weight loss medications, CBS News reporter Jennifer Jacobs said on X. The deal is expected to lower the drug price to under $150 per...
AbbVie, Ironwood Win FDA Approval for Linzess to Treat Children With Irritable Bowel Syndrome With Constipation
AbbVie, Ironwood Win FDA Approval for Linzess to Treat Children With Irritable Bowel Syndrome With Constipation
Nov 5, 2025
01:01 PM EST, 11/05/2025 (MT Newswires) -- AbbVie ( ABBV ) and Ironwood Pharmaceuticals ( IRWD ) received US Food and Drug Administration approval for Linzess (linaclotide) to treat children aged seven years and older with irritable bowel syndrome with constipation. The approval, the first therapy cleared for pediatric patients with the condition, was based on data from adult studies...
Copyright 2023-2026 - www.financetom.com All Rights Reserved